Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00932_DB01076_nanopub.RAE-iT7TokmPtADTqyLN-cJ-ighF9hhwpUZNM95ESdrF4#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00932_DB01076 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00932_DB01076 label "DDI between Tipranavir and Atorvastatin - Tipranavir, co-administered with Ritonavir, increases the adverse/toxic effects of Atorvastatin. Concomitant therapy should be avoided. [drugbank_resource:DB00932_DB01076]" assertion.
- drugbank_resource:DB00932_DB01076 identifier "drugbank_resource:DB00932_DB01076" assertion.
- drugbank_resource:DB00932_DB01076 title "DDI between Tipranavir and Atorvastatin - Tipranavir, co-administered with Ritonavir, increases the adverse/toxic effects of Atorvastatin. Concomitant therapy should be avoided." assertion.
- drugbank:DB00932 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00932_DB01076 assertion.
- drugbank:DB01076 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00932_DB01076 assertion.